– Bloomberg
Why Marker Therapeutics (MRKR) Stock Is Trading Sharply Higher
Marker Therapeutics, Inc. (NASDAQ: MRKR) shares are trading higher by 18.7% to $5.15 Monday morning after the company announced the European Medicines Agency granted MT-401 an